High chymotrypsin-like activity in the plasma of patients with newly diagnosed multiple myeloma treated with bortezomib is predictive of a better response and longer PFS

por Romaniuk, Wioletta, Bolkun, Lukasz, Kalita, Joanna, Galar, Marzenna, Bernatowicz, Malgorzata, Ostrowska, Halina, Kloczko, Janusz
Publicado 2018

Karyopherin enrichment and compensation fortifies the nuclear pore complex against nucleocytoplasmic leakage

por Kalita, Joanna, Kapinos, Larisa E., Zheng, Tiantian, Rencurel, Chantal, Zilman, Anton, Lim, Roderick Y.H.
Publicado 2022